SEC Form 4 · accession 0000911916-16-000622
CoLucid Pharmaceuticals, Inc. · CLCD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marvin L White
Director
Period of report
Jul 1, 2016
Accepted (ET)
Jul 5, 2016 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.62 | Jul 1, 2016 | A | 1,630 | A | Jul 1, 2016 | Jul 1, 2026 | Common Stock | 1,630 | 1,630 | D |
Explanation of responses
- F1This option was issued to the reporting person pursuant to the CoLucid Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash compensation of $13,750.